Deprescribing proton pump inhibitors Evidence-based clinical practice guideline

被引:3
|
作者
Farrell, Barbara [1 ,2 ,3 ]
Pottie, Kevin [4 ,5 ,6 ]
Thompson, Wade [5 ]
Boghossian, Taline [7 ]
Pizzola, Lisa [6 ]
Rashid, Farah Joy [7 ]
Rojas-Fernandez, Carlos [8 ,9 ]
Walsh, Kate [10 ]
Welch, Vivian [5 ,11 ]
Moayyedi, Paul [12 ]
机构
[1] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[3] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada
[4] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Bruyere Res Inst, Ottawa, ON, Canada
[7] Ottawa Hosp, Dept Pharm, Ottawa, ON, Canada
[8] Univ Waterloo, Geriatr Pharmacotherapy, Schlegel UW Res Inst Ageing, Waterloo, ON, Canada
[9] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[10] Toronto Cent Community Care Access Ctr, Toronto, ON, Canada
[11] Bruyere Res Inst, Methods Ctr, Ottawa, ON, Canada
[12] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; PANTOPRAZOLE; 20; MG; MAINTENANCE TREATMENT; LONG-TERM; ON-DEMAND; CONTROLLED TRIAL; PRIMARY-CARE; THERAPY; ESOPHAGITIS; MANAGEMENT;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline development, review, and endorsement processes. Methods Five health professionals (1 family physician, 3 pharmacists, and 1 gastroenterologist) and 5 nonvoting members comprised the overall team; members disclosed conflicts of interest. The guideline process included the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, with a detailed evidence review in in-person, telephone, and online meetings. Uniquely, the guideline development process included a systematic review of PPI deprescribing trials and examination of reviews of the harm of continued PPI use. Narrative syntheses of patient preferences and resource-implication literature informed recommendations. The team refined guideline content and recommendation wording through consensus and synthesized clinical considerations to address common front-line clinician questions. The draft guideline was distributed to clinicians and then to health care professional associations for review and revisions made at each stage. A decision-support algorithm was developed in conjunction with the guideline. Recommendations This guideline recommends deprescribing PPIs (reducing dose, stopping, or using "on-demand" dosing) in adults who have completed a minimum of 4 weeks of PPI treatment for heartburn or mild to moderate gastroesophageal reflux disease or esophagitis, and whose symptoms are resolved. The recommendations do not apply to those who have or have had Barrett esophagus, severe esophagitis grade C or D, or documented history of bleeding gastrointestinal ulcers. Conclusion This guideline provides practical recommendations for making decisions about when and how to reduce the dose of or stop PPIs. Recommendations are meant to assist with, not dictate, decision making in conjunction with patients.
引用
收藏
页码:354 / 364
页数:11
相关论文
共 50 条
  • [31] Pharmacotherapy of osteoporosis:: Evidence-based clinical practice
    Fassbender, WJ
    Stumpf, UC
    Jockenhövel, F
    MEDIZINISCHE KLINIK, 2006, 101 : 173 - 177
  • [32] The role of hypnotherapy in evidence-based clinical practice
    Griffiths, M. J.
    ORAL DISEASES, 2017, 23 (04) : 420 - 423
  • [33] Evidence-Based Clinical Practice Guideline: Inhaled Nitric Oxide for Neonates With Acute Hypoxic Respiratory Failure
    DiBlasi, Robert M.
    Myers, Timothy R.
    Hess, Dean R.
    RESPIRATORY CARE, 2010, 55 (12) : 1717 - 1745
  • [34] Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    Heidelbaugh, J. J.
    Metz, D. C.
    Yang, Y. -X.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (06) : 582 - 591
  • [35] Korean medicine clinical practice guideline on acupuncture for acute ankle sprains in adults: Evidence-based approach
    Choi, Jiae
    Jun, Ji Hee
    Kim, Jong Uk
    Choi, Tae-Young
    Lee, Ju Ah
    Yook, Tae Han
    Kim, Tae Hun
    Lee, Myeong Soo
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2017, 12 : 182 - 188
  • [36] Summary of evidence-based nutritional recommendations of the Clinical Practice Guideline for the management of patients with Parkinson's disease
    Baladia, Eduard
    Frutos Perez-Surio, Alberto
    Martinez-Rodriguez, Rodrigo
    NUTRICION HOSPITALARIA, 2016, 33 (03) : 749 - 760
  • [37] Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
    Mistry, Suresh D.
    Trivedi, Hiren R.
    Parmar, Dinesh M.
    Dalvi, Prashant S.
    Jiyo, Chacko
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (02) : 183 - 186
  • [38] Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors
    Gendre, Pauline
    Mayol, Severine
    Mocquard, Julie
    Huon, Jean-Francois
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (06) : 718 - 728
  • [39] Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review
    Jérôme Nguyen-Soenen
    Cédric Rat
    Jean-Pascal Fournier
    European Journal of Clinical Pharmacology, 2020, 76 : 17 - 21
  • [40] Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review
    Nguyen-Soenen, Jerome
    Rat, Cedric
    Fournier, Jean-Pascal
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (01) : 17 - 21